$2.21
Today
as of Sep 4, 16:51 ET
Last 30 days
Recent Press Releases & News
Pulmonx Shares Fall Following Recent Gains
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Pulmonx to Participate in Upcoming Investor Conferences
Overview
52-week range
$1.13
$2.89
61% of range
Avg surprise (last 2)
+3.9%
Avg reaction (last 1)
-8.3%
0% positive
Latest IV / EM
188%
EM ±29.4% · $3 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.24 | — | — | — | — | financials |
| Tue Mar 31, 2026 | Mar 2026 | $-0.33 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.34 | — | — | — | — | financials |
| Wed Jul 30, 2025 | Jun/2025 | $-0.38 | $-0.40 | +5.0% | — | — | earnings |
| Wed Apr 30, 2025 | Mar/2025 | $-0.36 | $-0.37 | +2.7% | — | -8.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.36 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.39 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.36 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.39 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.43 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-0.42 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $23M | $21M | — | $22M | $24M | $23M | — | $20M |
| Cost of revenue | $5M | $5M | — | $5M | $7M | $6M | — | $5M |
| Gross profit | $18M | $16M | — | $16M | $17M | $16M | — | $15M |
| Operating income | $-9M | $-13M | — | $-14M | $-15M | $-15M | — | $-14M |
| Net income | $-10M | $-14M | — | $-14M | $-15M | $-14M | — | $-14M |
| EPS (diluted) | $-0.24 | $-0.33 | — | $-0.34 | $-0.38 | $-0.36 | — | $-0.36 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $56M | $62M | $70M | $77M | $75M | $75M | $71M | $63M |
| Inventory | $16M | $16M | $16M | $16M | $16M | $17M | $17M | $17M |
| Total current assets | $88M | $93M | $102M | $111M | $120M | $124M | $136M | $141M |
| Total assets | $115M | $120M | $129M | $138M | $147M | $151M | $163M | $167M |
| Long-term debt | $37M | $37M | $37M | $37M | $37M | $29M | $34M | $37M |
| Total liabilities | $76M | $74M | $75M | $78M | $78M | $73M | $77M | $73M |
| Total equity | $39M | $46M | $54M | $60M | $69M | $78M | $86M | $94M |